Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 5:26 pm Purchase | 13G | ENHABIT INC EHAB | Flynn James E | 4,997,746 9.97% | 2,001,746 (+66.81%) | View |
| 2024-02-12 5:26 pm Sale | 13G | DOCGO INC DCGO | Flynn James E | 5,320,139 5.12% | -694,611 (-11.55%) | View |
| 2024-02-12 5:25 pm Sale | 13G | CABALETTA BIO INC CABA | Flynn James E | 2,007,729 4.69% | -332,389 (-14.20%) | View |
| 2024-02-12 5:24 pm Purchase | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Flynn James E | 14,793,264 7.86% | 2,113,613 (+16.67%) | View |
| 2024-02-12 5:24 pm Sale | 13G | AMEDISYS INC AMED | Flynn James E | 0 0% | -1,794,000 (Position Closed) | View |
| 2024-02-12 5:23 pm Purchase | 13G | ADAPTHEALTH CORP AHCO | Flynn James E | 27,654,923 9.98% | 5,981,026 (+27.60%) | View |
| 2024-02-12 5:23 pm Sale | 13G | ABEONA THERAPEUTICS INC NE ABEO | Flynn James E | 869,565 3.39% | -869,565 (-50.00%) | View |
| 2024-02-01 5:29 pm Purchase | 13G | CALCIMEDICA INC CALC | Flynn James E | 2,613,012 9.99% | 2,336,214 (+844.01%) | View |
| 2024-02-01 5:28 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 4,478,592 5.25% | 545,455 (+13.87%) | View |
| 2024-02-01 5:26 pm Purchase | 13G | WINDTREE THERAPEUTICS INC WINT | Flynn James E | 608,272 7.59% | 608,272 (New Position) | View |
| 2024-01-12 3:36 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Flynn James E | 2,260,398 6.08% | 2,260,398 (New Position) | View |
| 2023-12-18 4:45 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | Flynn James E | 6,401,000 8.84% | 6,401,000 (New Position) | View |
| 2023-11-30 5:46 pm Purchase | 13G | OSCAR HEALTH INC OSCR | Flynn James E | 10,537,491 5.52% | 10,537,491 (New Position) | View |
| 2023-11-20 3:19 pm Purchase | 13G | MALLINCKRODT PLC SHS MNK | Flynn James E | 1,505,969 7.65% | 1,505,969 (New Position) | View |
| 2023-11-13 4:46 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 9,677,857 9.22% | 32,892 (+0.34%) | View |
| 2023-11-13 08:30 am Purchase | 13G | PRELUDE THERAPEUTICS INC PRLD | Flynn James E | 3,222,690 7.68% | 3,222,690 (New Position) | View |
| 2023-10-26 4:55 pm Purchase | 13G | NKARTA INC NKTX | Flynn James E | 3,400,000 6.93% | 1,980,128 (+139.46%) | View |
| 2023-10-20 2:02 pm Sale | 13G | SILK RD MED INC SILK | Flynn James E | 0 0% | -1,396,640 (Position Closed) | View |
| 2023-10-18 4:41 pm Purchase | 13G | DOCGO INC DCGO | Flynn James E | 6,014,750 5.8% | 6,014,750 (New Position) | View |
| 2023-10-04 5:09 pm Sale | 13G | TERNS PHARMACEUTICALS INC TERN | Flynn James E | 0 0% | -2,851,287 (Position Closed) | View |